Home Cart Sign in  
Chemical Structure| 1454846-35-5 Chemical Structure| 1454846-35-5

Structure of Lorlatinib
CAS No.: 1454846-35-5

Chemical Structure| 1454846-35-5

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Lorlatinib (PF-06463922) is a selective, orally active, brain-penetrant, ATP-competitive ROS1/ALK inhibitor with anticancer activity, having Kis of <0.025 nM, <0.07 nM, and 0.7 nM for ROS1, wild-type ALK, and ALKL1196M, respectively. Lorlatinib targets EML4-ALK and inhibits ALK phosphorylation with IC50s of 15-43 nM (ALKL1196), 14-80 nM (ALKG1269A), 38-50 nM (ALK1151Tins), and 77-113 nM (ALKG1202R).

Synonyms: PF-06463922; PF-6463922

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Lorlatinib

CAS No. :1454846-35-5
Formula : C21H19FN6O2
M.W : 406.41
SMILES Code : N#CC1=C(C2=CN=C(C(O[C@@H](C3=CC(F)=CC=C3C4=O)C)=C2)N)C(CN4C)=NN1C
Synonyms :
PF-06463922; PF-6463922
MDL No. :MFCD28144520
InChI Key :IIXWYSCJSQVBQM-LLVKDONJSA-N
Pubchem ID :71731823

Safety of Lorlatinib

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302
Precautionary Statements:P280-P305+P351+P338

Related Pathways of Lorlatinib

RTK

Isoform Comparison

Biological Activity

Target
  • ALK

    ALK (L1196M), Ki:0.07 nM

    ROS1, Ki:<0.07 nM

In Vitro:

Cell Line
Concentration Treated Time Description References
Ba/F3 cells 300, 600, 1000 nM 2-4 weeks Identify lorlatinib-resistant ALK compound mutations PMC6441848
Ba/F3 cells 300, 600, 1000 nM 2-4 weeks Through ENU mutagenesis screening, lorlatinib-resistant ALK compound mutations were identified, including compound mutations of I1171N and G1202R. PMC6441848
Ba/F3 cells 10, 100, 300, 600, 1000 nM 3 h The inhibitory effect of lorlatinib on the ALK-G1202R + G1269A double mutation was evaluated, and the results showed that this mutation was resistant to lorlatinib. PMC6441848
NCI-H3122 4 µM 2–4 months To study the evolution of resistance to different ALK inhibitors in NCI-H3122 cells, it was found that Lorlatinib could select for cells with strong resistance to high concentrations of ALK inhibitors. PMC7224215
JFCR-028-3-LR1000#1 1 or 3 µM 1 week To establish Lorlatinib-resistant cell models and study their cross-resistance to Lorlatinib and other ALK-TKIs. PMC8931094
JFCR-028-3 cells 100 nM 9 days To evaluate the effect of Lorlatinib on JFCR-028-3 cells, it was found that MIG6 depletion increased resistance to ALK-TKIs. PMC10807714

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
BALB-c nu/nu mice JFCR-041-2 cell xenograft model Oral 10 mg/kg Once daily for 5-6 days/week Investigate lorlatinib resistance mechanisms PMC6441848
mouse EML4-ALK L1196M intraperitoneal injection 0.5, 2, 10 mg/kg daily for 2 weeks Lorlatinib suppressed ALK-driven tumor growth in a dose-dependent manner, but LUSC showed significant resistance to lorlatinib treatment PMC10824105
BALB/c nu/nu mice Mouse model of EML4-ALK-G1202R mutation Oral 10, 30, 50 mg/kg Once daily for 5-6 days/week In the mouse model of EML4-ALK-G1202R mutation, lorlatinib initially significantly shrank the tumor, but the tumor eventually regrew, and the ALK-G1202R + G1269A double mutation was identified. PMC6441848
mouse EML4-ALK L1196M model intraperitoneal injection 0.5, 2, 10 mg/kg daily for 2 weeks To investigate the inhibitory effect of Lorlatinib on tumors in the EML4-ALK L1196M mouse model, it was found that Lorlatinib dose-dependently suppressed ALK-driven tumor growth, with LUAD showing significant decrease in tumor sizes at 0.5 and 2 mg/kg Lorlatinib treatments, while LUSC showed no significant change. PMC10824105
NOD/SCID gamma mice Subcutaneous xenograft model Oral 3 mg/kg Once daily, 4 days on, 3 days off Evaluate the inhibitory effect of lorlatinib alone or in combination with selumetinib on ROS1 fusion-positive tumors. PMC8034819
mice NSG mice oral 6 mg/kg daily administration for 3 weeks To evaluate the therapeutic efficacy of Lorlatinib in ALK-positive NSCLC in vivo, it was found that Lorlatinib significantly inhibited tumor growth. PMC7224215
BALB/c nude mice JFCR-028-3 cell xenograft model Oral 10 mg/kg 5 days per week for 4 weeks To evaluate the antitumor effect of Lorlatinib in vivo on JFCR-028-3 cell xenograft model, it was found that MIG6 depletion conferred resistance to ALK-TKIs, and combination therapy could overcome the resistance. PMC10807714

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT05167500 Metastatic Non Small Cell Lung... More >> Cancer Less << COMPLETED 2022-12-30 Hospital Clínico Santiago, San... More >>tiago De Compostela, A Coru?a, 15706, Spain|Hospital Universitario Central de Asturias, Oviedo, Asturias, 33011, Spain|Hospital Germans Trias i Pujol, Badalona, Barcelona, 08916, Spain|Hospital Puerta del Mar, Cadiz, Cádiz, 11009, Spain|Hospital Universitario Insular de Gran canaria, Las Palmas De Gran Canaria, Gran Canaria, 35016, Spain|Complejo Hospitalario Universitario A Coru?a, A Coru?a, La Coru?a, 15006, Spain|Centro Oncológico de Galicia, A Coru?a, La Coru?a, 15009, Spain|Hospital del Mar, Barcelona, 08003, Spain|Hospital Universitari Quiron Dexeus, Barcelona, 08028, Spain|Hospital Clinic de Barcelona, Barcelona, 08036, Spain|Hospital Universitario de Burgos, Burgos, 09006, Spain|Hospital Dr. Josep Trueta, Girona, 17007, Spain|Hospital Universitario de Jaén, Jaén, 23007, Spain|Complejo Asistencial Universitario de León, León, 24071, Spain|Hospital Gregorio Mara?ón, Madrid, 28007, Spain|Hospital Clínico San Carlos, Madrid, 28040, Spain|Hospital 12 De Octubre, Madrid, 28041, Spain|Hospital Puerta de Hierro, Madrid, 28222, Spain|Hospital Fundación de Alcorcón, Madrid, 28922, Spain|Hospital Virgen del Rocio, Sevilla, 41013, Spain|Complejo Hospitalario de Toledo, Toledo, 45004, Spain|Hospital Universitari i Politécnic La Fe, Valencia, 46009, Spain|Hospital Clínico de Valencia, Valencia, 46010, Spain|Hospital General de Valencia, Valencia, 46014, Spain|Hospital Clínico Lozano Blesa, Zaragoza, 50009, Spain Less <<
NCT06282874 Carcinoma, Non-Small-Cell Lung... More >>|Brain Metastases|Leptomeningeal Metastasis Less << PHASE4 NOT_YET_RECRUITING 2027-03-01 Guangdong Provincial Perople's... More >> Hospital, Guangzhou, Other (Non U.s.), 510080, China Less <<
NCT04621188 Non Small Cell Lung Cancer Met... More >>astatic Less << PHASE2 RECRUITING 2025-01-26 Centre Hospitalier du Pays d'A... More >>ix, Aix-en-Provence, 13616, France|Centre Paul Papin, Angers, 49055, France|Angers - CHU, Angers, France|Annecy - CH, Annecy, France|Antony - H?pital privé, Antony, France|Avignon - CH, Avignon, France|Centre Hospitalier de la C?te Basque, Bayonne, 64100, France|Bordeaux - CHU, Bordeaux, France|Bordeaux - Institut Bergonie, Bordeaux, France|Bordeaux - Polyclinique, Bordeaux, France|AP-HP H?pital Ambroise Paré, Boulogne, 92104, France|Caen - CHU C?te de Nacre, Caen, 14000, France|Chauny - CH, Chauny, France|Cholet - CH, Cholet, France|Clermont-Ferrand - CHU, Clermont-Ferrand, France|Colmar - CH, Colmar, France|Centre Hospitalier Intercommunal de Créteil, Créteil, 94000, France|Dijon - CRLCC, Dijon, France|CHRU Grenoble, Grenoble, France|Centre Hospitalier - Pneumologie, Le Mans, 72000, France|H?pital Calmette, Lille, 59037, France|Centre Léon Bérard, Lyon, 69373, France|Institut Paoli Calmettes, Marseille, 13273, France|Marseille H?pital Nord, Marseille, 13915, France|GRH Mulhouse Sud-Alsace, Mulhouse, France|AP-HP H?pital Cochin, Paris, 75014, France|AP-HP Hopital Tenon - Pneumologie, Paris, 75020, France|AP-HP H?pital Bichat, Paris, 75877, France|Paris - Curie, Paris, France|Lyon - URCOT, Pierre-Bénite, France|Rouen - CHU, Rouen, France|Nouvel H?pital Civil - H?pitaux Universitaires de Strasbourg, Strasbourg, 67091, France|H?pital Foch, Suresnes, 92151, France|CHU Toulouse - Pneumologie, Toulouse, France|CHU Bretonneau, Tours, 37044, France|Valenciennes - Clinique, Valenciennes, France|Vandoeuvre-lès-Nancy - CHU, Vand?uvre-lès-Nancy, France Less <<
NCT06378892 Non Small Cell Lung Cancer Met... More >>astatic|ALK Gene Mutation Less << PHASE2 RECRUITING 2025-05-28 Centro di Riferimento Oncologi... More >>co (CRO) IRCCS, Aviano, 33081, Italy|Azienda Ospedaliero-Universitaria Careggi Oncologia Medica, Firenze, 50134, Italy|Azienda USL Toscana Nord Ovest Oncologia Medica, Ospedale Versilia, Lido Di Camaiore, 55049, Italy|Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino amadori", Meldola, 47014, Italy|Fondazione IRCCS San Gerardo dei Tintori, Monza, 20900, Italy|IOV Istituto Oncologico Veneto IRCCS, Padova, 35128, Italy|Azienda Ospedaliero-Universitaria di Parma, Parma, 43126, Italy|Azienda Ospedaliera di Perugia, Perugia, 06129, Italy|Azienda Sanitaria Universitaria Friuli Centrale (ASU FC), Udine, 33010, Italy Less <<
NCT05740943 Stage III NSCLC|Surgery PHASE2 RECRUITING 2026-12-31 Guangdong Provincial People's ... More >>Hospital, Guangzhou, Guangdong, 510080, China Less <<
NCT06410040 ALK-positive Non-small Cell Lu... More >>ng Cancer|Brain Metastases|Meningeal Metastasis Less << ACTIVE_NOT_RECRUITING 2024-06-30 Sichuan cancer hospital, Cheng... More >>du, Sichuan, 610000, China Less <<
NCT02927340 Non-Small Cell Lung Cancer (NS... More >>CLC) Less << PHASE2 UNKNOWN 2025-05-23 Massachusetts general Hospital... More >>, Boston, Massachusetts, 02114, United States Less <<
NCT04111705 Non Small Cell Lung Cancer Met... More >>astatic Less << PHASE2 ACTIVE_NOT_RECRUITING 2025-01-25 Angers - CHU, Angers, France|A... More >>nnecy - CH, Annecy, France|Bayonne - CH, Bayonne, France|Besan?on - CHU, Besan?on, France|Bordeaux - CHU H?pital Haut-Lévèque, Bordeaux, France|Boulogne - Ambroise Paré, Boulogne-Billancourt, France|Caen - CHU C?te de Nacre, Caen, 14000, France|Colmar - CH, Colmar, France|Créteil - CHI, Créteil, France|Dijon - CRLCC, Dijon, France|Grenoble - CHU, Grenoble, France|Le Mans - CHG, Le Mans, France|Lille - H?pital Calmette, Lille, France|Lyon - CRLCC, Lyon, France|Marseille - AP-HM H?pital Nord, Marseille, France|Marseille - Institut Paoli Calmette, Marseille, France|Montpellier - CHU, Montpellier, France|Montpellier - Clinique, Montpellier, France|Mulhouse - GHRMSA, Mulhouse, France|Nantes - CRLCC, Nantes, France|Orléans - CHR, Orléans, 45000, France|Paris - APHP - Hopital Tenon, Paris, 75020, France|Paris - APHP Bichat, Paris, France|Paris - Curie, Paris, France|Paris - H?pital Cochin, Paris, France|Lyon - URCOT, Pierre-Bénite, France|Saint Quentin - CH, Saint Quentin, 02100, France|Strasbourg - Nouvel H?pital Civil, Strasbourg, France|Suresnes - Hopital Foch, Suresnes, 92151, France|Toulon - CHI, Toulon, 83000, France|Toulouse - CHU, Toulouse, France|Vandoeuvre-lès-Nancy - CRLCC, Vandoeuvre-lès-Nancy, France Less <<
NCT05144997 Non-Small-Cell Lung Cancer|NSC... More >>LC Less << PHASE4 ACTIVE_NOT_RECRUITING 2026-12-28 UC Irvine Health, Orange, Cali... More >>fornia, 92868-3201, United States|The First affiliated Hospital of Anhui Medical University, Hefei, Anhui, 230022, China|Beijing Chest Hospital, Capital Medical University, Beijing, Beijing, 100000, China|Beijing Cancer Hospital, Beijing, Beijing, 100142, China|Fujian Cancer Hospital, Fuzhou, Fujian, 350014, China|Guangdong Provincial People's Hospital, Guangzhou, Guangdong, 510080, China|Hunan Cancer Hospital, Changsha, Hunan, 410006, China|General Hospital of Eastern Theater Command, Nanjing, Jiangsu, 210002, China|The first hospital of jilin university, Changchun City, Jilin, 130021, China|Jilin Cancer Hospital, Changchun, Jilin, 130000, China|Jilin Cancer Hospital, Changchun, Jilin, 130028, China|Sir Run Shaw Hospital, Hangzhou, Qiantang District, 310016, China|The Second Affiliated Hospital of PLA Air Force Medical University, Xi'an City, Shaanxi, 710038, China|Shanghai Chest Hospital, Shanghai, Shanghai, 200030, China|Sichuan Cancer Hospital, Chengdu, Sichuan, 610000, China|Sichuan Cancer Hospital, Chengdu, Sichuan, 610041, China|The First Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, Zhejiang, 310003, China|The Second Affiliated Hospital of Zhejiang University College of Medicine, Hangzhou, Zhejiang, 310009, China|Zhejiang Cancer Hospital, Hangzhou, Zhejiang, 310022, China|The Second Affiliated Hospital of Zhejiang University College of Medicine, Hangzhou, Zhejiang, 310052, China|University Cancer Hospital, Beijing, 100000, China|Beijing Chest Hospital, Capital Medical University, Beijing, 101149, China|Fudan University Shanghai Cancer Center, Shanghai, 200032, China|CHU de Rennes - H?pital Pontchaillou, Rennes, 35033, France|Institut Gustave Roussy, Villejuif Cedex, 94805, France|Healthcare Global Enterprises, Bengaluru, Karnataka, 560027, India|Bhakti Vedanta Hospital & Research Institute, Thane/Mumbai, Maharashtra, 401107, India|Bhaktivedanta Hospital & Research Institute, Thane, Maharashtra, 401107, India|Aichi Cancer Center Hospital, Nagoya, Aichi, 464-8681, Japan|National University Hospital, Singapore, 119074, Singapore|National Cancer Centre Singapore, Singapore, 168583, Singapore|National Cancer Centre Singapore, Singapore, 169610, Singapore|Hospital Vall D′Hebron, Barcelona, Catalu?a, 08035, Spain|Hospital Universitari Vall d'Hebron, Barcelona, 08035, Spain|National Taiwan University Hospital, Taipei, 10002, Taiwan Less <<
NCT03542305 Renal Impairment PHASE1 COMPLETED 2020-02-20 Anaheim Clinical Trials, LLC, ... More >>Anaheim, California, 92801, United States|Prism Clinical Research, LLC, Saint Paul, Minnesota, 55114, United States Less <<
NCT05297890 Advanced or Metastatic ROS1-Po... More >>sitive Non-Small Cell Lung Cancer Less << PHASE2 ACTIVE_NOT_RECRUITING 2025-11-25 Guangdong Provincial People's ... More >>hospital, Guangzhou, Guangdong, 510080, China|Beijing Cancer Hospital, Beijing, China|Cancer Hospital Chinese Academy of Medical Sciences, Beijing, China|The First Hospital of Jilin University, Changchun, China|Hunan Cancer Hospital, Changsha, China|Sichuan Cancer Hospital & Institute, Chengdu, China|West China Hospital of Sichuan University, Chengdu, China|Chinese PLA Army Medical Center, Chongqing, China|Fujian Cancer Hospital, Fuzhou, China|Sun Yat-sen University Cancer Center, Guangzhou, China|The first Affiliated hospital, Sun Yat-Sen University, Guangzhou, China|Zhejiang Cancer Hospital, Hangzhou, China|Harbin Medical University Cancer Hospital, Harbin, China|The First Affiliated Hospital of Anhui Medical University, Hefei, China|Shandong Cancer Hospital&Institute, Jinan, China|Yunnan Cancer Hospital, Kunming, China|The First Affiliated Hospital of Nanchang University, Nanchang, China|The Second Affiliated Hospital of Nanchang University, Nanchang, China|Jiangsu Province Hospital, Nanjing, China|Fudan University Shanghai Cancer Center, Shanghai, China|Shanghai Pulmonary Hospital, Shanghai, China|Liaoning Cancer Hospital and Institute, Shenyang, China|Shanxi Cancer hospital, Taiyuan, China|Tianjin Medical University Cancer Institute & Hospital, Tianjin, China|The 1st Affiliated hospital of Wenzhou Medical University, Wenzhou, China|Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China|Tangdu Hospital of The fourth Military Medical University Peoples Liberation Army of China, Xi'an, China|Xiamen Humanity Hospital, Xiamen, China|Henan Cancer Hospital, Zhengzhou, China|Henan Provincial People's Hospital, Zhengzhou, China|The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China Less <<
NCT06487078 ALK+ Non-Small-Cell Lung Carci... More >>noma Less << NOT_YET_RECRUITING 2028-11-30 -
NCT05224609 Moderate Hepatic Impairment|Se... More >>vere Hepatic Impairment|Healthy Volunteers Less << PHASE1 COMPLETED 2024-08-13 Orange County Research Center,... More >> Tustin, California, 92780, United States|Genesis Clinical Research, LLC, Tampa, Florida, 33603, United States|Prism Research LLC dba Nucleus Network, Saint Paul, Minnesota, 55114, United States Less <<
NCT03439215 Carcinoma, Non-Small-Cell Lung PHASE2 UNKNOWN 2025-06-22 IRCCS - Istituto Scientifico R... More >>omagnolo per lo Studio e la Cura dei Tumori (IRST)- Oncologia Medica, Meldola, Forlì- Cesena, 47014, Italy|Sacro Cuore- Don Calabria Hospital- U.O.C. Oncologia Medica, Negrar, Verona, 37024, Italy|Istituto Toscano Tumori Ospedale San Donato- U.O.C. di Oncologia Medica Dipartimento di Oncologia USL-8, Arezzo, 52100, Italy|Azienda Ospedaliera di Rilievo Nazionale "S.G. Moscati", Avellino, 83100, Italy|IRCCS Istituto Tumori Giovanni Paolo II, Bari, 70124, Italy|IRCCS A.O.U. San Martino- IST- Istituto Nazionale per la Ricerca sul Cancro- U.O.S. Tumori Polmonari, Genova, 16132, Italy|Istituto Europeo di Oncologia - Divisione di Oncologia Toracica, Milano, 20141, Italy|A.O.U. Policlinico di Modena- Oncologia Ematologia e Malattie Apparato Respiratorio, Modena, 41124, Italy|A.O. San Gerardo, Monza, 20900, Italy|Istituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, 80131, Italy|Istituto Oncologico Veneto IRCCS- UOS Oncologia Toracica UOC. Oncologia Medica 2, Padova, 35128, Italy|Casa di Cura La Maddalena- U.O. Oncologia medica, Palermo, 90146, Italy|Azienda Ospedaliera Universitaria di Parma- Struttura Complessa di Oncologia Medica, Parma, 43126, Italy|Azienda Ospedaliera di Perugia- S.C. Oncologia Medica, Perugia, 06132, Italy|Ospedale di Ravenna- Oncologia Medica, Ravenna, 48121, Italy|Ospedale "Infermi" Rimini, Rimini, 47900, Italy|ASST della Valle Olona - Ospedale di Saronno, Saronno, 21047, Italy|A.O.U. San Luigi Gonzaga, Torino, 10043, Italy|Azienda ULSS 9 TREVISO-UOC Oncologia Medica, Treviso, 31100, Italy|Policlinico 'G.B.Rossi' Borgo Roma - A.O.U. Integrata (Giampaolo Tortora)- Oncologia Medica, Verona, 37134, Italy Less <<
NCT03178071 Non Small Cell Lung Cancer ALK... More >> Positive or ROS1 Positive Less << NO_LONGER_AVAILABLE - Arizona Oncology Associates, P... More >>C - NAHOA, Sedona, Arizona, 86336, United States|Pacific Shores Medical Group, Huntington Beach, California, 92648, United States|Pacific Shores Medical Group, Irvine, California, 92618, United States|Pacific Shores Medical Group, Long Beach, California, 90808, United States|Pacific Shores Medical Group, Long Beach, California, 90813, United States|Kaiser Permanente, Oakland Medical Center, Oakland, California, 94611, United States|UC Irvine Health / Chao Family Comprehensive Cancer Center, Orange, California, 92868, United States|University of California Irvine/Chao Family Comprehensive Cancer Center, Orange, California, 92868, United States|Kaiser Permanente, South Sacramento Medical Center, Sacramento, California, 95823, United States|Kaiser Permanente, San Francisco Medical Center, San Francisco, California, 94115, United States|Kaiser Permanente, Vallejo Medical Center, Vallejo, California, 94589, United States|Memorial Cancer Institute at Memorial Hospital West, Pembroke Pines, Florida, 33028, United States|University Cancer & Blood Center, Llc, Athens, Georgia, 30607, United States|University of Chicago Medical Center, CCD, Chicago, Illinois, 60637, United States|University of Chicago Medical Center, Chicago, Illinois, 60637, United States|Elmhurst Memorial Hospital Nancy W. Knowles Cancer Center, Elmhurst, Illinois, 60126, United States|Edward Cancer Center, Naperville, Illinois, 60540, United States|Massachusetts General Hospital, Boston, Massachusetts, 02114, United States|Brigham and Women's Hospital, Boston, Massachusetts, 02115, United States|Dana Farber Cancer Institute/Pharmacy, Boston, Massachusetts, 02215, United States|Dana Farber Cancer Institute, Boston, Massachusetts, 02215, United States|University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, 48109, United States|Karmanos Cancer Institute, Detroit, Michigan, 48201, United States|Henry Ford Health System, Detroit, Michigan, 48202, United States|Henry Ford Hospital, Detroit, Michigan, 48202, United States|Karmanos Cancer Institute Weisberg Cancer Treatment Center, Farmington Hills, Michigan, 48334, United States|Siteman Cancer Center - West County, Creve Coeur, Missouri, 63141, United States|Washington University School of Medicine, Saint Louis, Missouri, 63110, United States|Siteman Cancer Center - South County, Saint Louis, Missouri, 63129, United States|Siteman Cancer Center - St Peters, Saint Peters, Missouri, 63376, United States|Rutgers Cancer Institute Of New Jersey, New Brunswick, New Jersey, 08903, United States|North Shore Hematology Oncology Associates, East Setauket, New York, 11733, United States|Memorial Sloan Kettering Cancer Center, New York, New York, 10022, United States|Breast and Imaging Center - 12th floor, New York, New York, 10065, United States|Memorial Sloan Kettering Cancer Center, New York, New York, 10065, United States|North Shore Hematology Oncology Associates, Patchogue, New York, 11772, United States|North Shore Hematology Oncology Associates, Port Jefferson Station, New York, 11776, United States|University of Cincinnati Medical Center, Cincinnati, Ohio, 45219, United States|Ohio State University East Hospital, Columbus, Ohio, 43205, United States|The Ohio State University Investigational Drug Services, Columbus, Ohio, 43210, United States|The Ohio State University James Cancer Hospital, Columbus, Ohio, 43210, United States|The Ohio State University, Columbus, Ohio, 43210, United States|Stefanie Spielman Comprehensive Breast Center, Columbus, Ohio, 43212, United States|The Ohio State University Martha Morehouse Medical Plaza, Columbus, Ohio, 43221, United States|CarePoint Gahanna, Gahanna, Ohio, 43230, United States|UPMC Hillman Cancer Center - Patient Clinic, Pittsburgh, Pennsylvania, 15232, United States|Charleston Hematology Oncology Associates, PA, Charleston, South Carolina, 29414, United States|Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas, Texas, 75246, United States|Seattle Cancer Care Alliance, Seattle, Washington, 98109, United States Less <<
NCT04127110 Non Small Cell Lung Cancer PHASE2 ACTIVE_NOT_RECRUITING 2025-11-24 Institut Jules Bordet-Hopital ... More >>Universitaire ULB, Brussels, 1000, Belgium|Cliniques Universitaires Saint-Luc, Brussels, BE 1200, Belgium|Universitair Ziekenhuis Antwerpen, Edegem, BE 2650, Belgium|CHU-UCL Namur - CHU Mont Godinne - UCL Namur, Yvoir, 5530, Belgium|Centre Hospitalier Avignon, Avignon, 84902, France|Assistance Publique Hopitaux Paris - Hopital Avicenne, Bobigny, France|CHU de Brest, Brest, 29200, France|Centre Hopitalier Intercommunal De Creteil, Créteil, 94010, France|Gustave Roussy, Villejuif, France|King Hussein Cancer Center, Amman, Jordan|The Netherlands Cancer Institute-Antoni Van Leeuwenhoekziekenhuis, Amsterdam, 1066 CX, Netherlands|Academisch Ziekenhuis Maastricht, Maastricht, Netherlands|Erasmus MC, Rotterdam, Netherlands|Oslo University Hospital - Radiumhospitalet, Oslo, Norway|Institut Catala d'Oncologia - ICO L'Hospitalet - Hospital Duran i Reynals, Hospitalet De Llobregat, Barcelona, 08908, Spain|Hospital Clinic Universitari de Barcelona, Barcelona, Spain|Hospital De La Santa Creu I Sant Pau, Barcelona, Spain|Institut Catala d'Oncologia - ICO Badalona - Hospital Germans Trias i Pujol, Barcelona, Spain|Hospital General Universitario Gregorio Maranon, Madrid, 28007, Spain|Clinica Universidad de Navarra - Clinica Universitaria De Navarra, Madrid, Spain|Hospital Universitario 12 De Octubre, Madrid, Spain|Hospital Universitario Ramon y Cajal, Madrid, Spain|Hospital Universitari Son Espases, Palma De Mallorca, Spain|Clinica Universidad de Navarra - Clinica Universitaria De Navarra, Pamplona, Spain|University Hospital Virgen del Rocio, Sevilla, Spain|The Christie NHS Foundation Trust, Manchester, United Kingdom Less <<
NCT06678555 Carcinoma, Non-Small-Cell Lung NOT_YET_RECRUITING 2025-09-30 Pfizer, Taipei, Taiwan
NCT06361589 ALK-positive Non-small Cell Lu... More >>ng Cancer|Real World Study Less << RECRUITING 2028-11-01 Sichuan cancer hospital, Cheng... More >>du, Sichuan, 610000, China Less <<
NCT04541706 Advanced Non-Small Cell Lung C... More >>ancer Less << PHASE4 COMPLETED 2022-07-20 Rajiv Gandhi Cancer Institute ... More >>And Research Centre, New Delhi, Delhi, 110085, India|The Gujarat Cancer and Research Institute, Ahmedabad, Gujarat, 380016, India|Hemato Oncology Clinic Ahmedabad Pvt. Ltd, Ahmedabad, Gujarat, 380054, India|Artemis hospital, Gurugram, Haryana, 122001, India|National Cancer Institute, Nagpur, Maharashtra, 441108, India|Apex Wellness Hospital, Nashik, Maharashtra, 422009, India|Grant Medical Foundation, Ruby Hall Clinic, Pune, Maharashtra, 411001, India|Sahyadri Clinical Research and Development Center, Pune, Maharashtra, 411004, India|Sahyadri Super Speciality Hospital, Pune, Maharashtra, 411004, India|Bhaktivedanta Hospital and Research Institute, Thane, Maharashtra, 401107, India|Yashoda Hospital, Hyderabad, Telangana State, 500082, India|Tata Medical Center, Kolkata, WEST Bengal, 700160, India Less <<
NCT03127618 - APPROVED_FOR_MARKETING - -
NCT03909971 Carcinoma, Non-Small-Cell Lung PHASE2 COMPLETED 2024-10-21 Gaoxin Hospital of The First A... More >>ffilated Hospital of Anhui Medical University, Hefei, Anhui, 230088, China|Beijing Cancer Hospital, Beijing, Beijing, 100142, China|Fujian Province Oncology Hospital, Fuzhou, Fujian, 350014, China|Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, 150081, China|Hunan Provincial Tumor Hospital/Division of Oncology, Changsha, Hunan, 410013, China|The first hospital of jilin university, Changchun, Jilin, 130021, China|Jilin Provincial Cancer Hospital, Changchun, Jilin, 130103, China|Tangdu Hospital of Fourth Military Medical University, Xi'an, Shanxi, 710000, China|Sichuan Province Cancer Hospital/Department of Pulmonary Tumor, Chengdu, Sichuan, 610041, China|West China Hospital, Sichuan University, Cancer center, Chengdu, Sichuan, 610041, China|The Second Affiliated Hospital of Zhejiang University College of Medicine, Hangzhou, Zhejiang, 310009, China|Sir Run Run Shaw Hospital of College of Medicine of Zhejiang University, Center for Oncology, Hangzhou, Zhejiang, 310016, China|Zhejiang Cancer Hospital, Hangzhou, Zhejiang, 310022, China|Fifth Medical Center of PLA General Hospital, Beijing, 100071, China|Beijing Chest Hospital, Capital Medical University, Beijing, 101149, China|Guangdong Provincial People's Hospital, Guangzhou, 510000, China|The First Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, Zhejiang, 310003, China|General Hospital of Eastern Theater Command, Nanjing, Jiangsu, China|Shanghai Chest Hospital, Shanghai, 200030, China|Fudan University Shanghai Cancer Center, Shanghai, 200032, China|Zhongshan Hospital, Fudan University, Shanghai, 200032, China Less <<
NCT03505554 Anaplastic Large Cell Lymphoma... More >>, ALK-Positive Less << PHASE2 RECRUITING 2025-12-24 Asst-Monza, Monza, Italy/MB, 2... More >>0900, Italy|UOC Ematologia, Ospedale S. Eugenio, Roma, Italy Less <<
NCT03612154 Nonsmall Cell Lung Cancer PHASE2 UNKNOWN 2023-12-31 National Cancer Center, Goyang... More >>-Si, Gyeonggi-do, 10408, Korea, Republic of Less <<
NCT04362072 Carcinoma|Non-Small-Cell Lung PHASE4 COMPLETED 2024-10-23 UCI Medical Center/Chao Family... More >> Comprehensive Cancer Center, Orange, California, 92868, United States|University Cancer & Blood Center, Llc, Athens, Georgia, 30607, United States|Rajiv Gandhi Cancer Institute And Research Centre, New Delhi, Delhi, 110085, India|Rajiv Gandhi Cancer Institute And Research Centre, New Delhi, DEL, 110085, India|Medanta-The Medicity, Gurgaon, Haryana, 122001, India|Healthcare Global Enterprises, Bengaluru, Karnataka, 560027, India|Bhakti Vedanta Hospital and Research Institute, Thane, Maharashtra, 401107, India|Fondazione IRCCS San Gerardo dei Tintori, Monza, Lombardia, 20900, Italy|IRCCS Ospedale San Raffaele, Milano, MI, 20132, Italy|Ospedale San Gerardo ASST Monza Oncologia Medica, Monza, Monza AND Brianza, 20900, Italy|Azienda Ospedaliera Dei Colli, Naples, Napoli, 80131, Italy|Azienda Sanitaria Territoriale (AST) Pesaro Urbino, Pesaro, Pesaro AND Urbino, 61122, Italy|Centro Riferimento Oncologico di Aviano - IRCCS SOC Oncologia Medica e dei Tumori Immunocorrelati, Aviano, PN, 33081, Italy|Azienda Ospedaliero Universitaria di Parma, Parma, PR, 43126, Italy|A.O. Ospedali Riuniti Marche Nord - Presidio San Salvatore - Muraglia, Pesaro, PU, 61122, Italy|Azienda Ospedaliera San Camillo Forlanini, Roma, Rome, 00152, Italy|Istituto di Candiolo IRCCS - Fondazione del Piemonte per l'Oncologia, Candiolo, Torino, 10060, Italy|AOU San Luigi Gonzaga, Orbassano (TO), TO, 10043, Italy|AO Santa Maria della Misericordia, Perugia, Umbria, 06132, Italy|Azienda Ospedaliera San Giuseppe Moscati, Avellino, 83100, Italy|Policlinico "G. Rodolico", Catania, 95123, Italy|Ms Pneumed Janusz Milanowski, Katarzyna Szmygin-Milanowska Spolka Jawna, Lublin, 20-064, Poland|Elkardia Lubelskie Centrum Kardiologii, Lublin, 20-091, Poland|Centrum Medyczne Luxmed Sp. z o.o., Lublin, 20-504, Poland|Centrum Medyczne EVOMED, Szczecin, 70-382, Poland|Dom Lekarski Centrum Medyczne Outlet Park, Szczecin, 70-784, Poland|Pracownia Medycyny Nuklearnej, 109 Szpital Wojskowy z Przychodnia SP ZOZ, Szczecin, 70-965, Poland|Dom Lekarski S.A., Szczecin, 71-064, Poland|Samodzielny Publiczny Szpital Kliniczny Nr 1 im. prof. Tadeusza Sokolowskiego Pomorskiego UM, Szczecin, 71-252, Poland|Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda, Madrid, 28222, Spain|Hospital Teresa Herrera (C.H.U.A.C), A Coru?a, 15006, Spain|Hospital de la Santa Creu i Sant Pau, Barcelona, 08025, Spain|Hospital Universitari Vall d'Hebron, Barcelona, 08035, Spain|Hospital de la Santa Creu i Sant Pau, Barcelona, 08041, Spain|ICO L'Hospitalet (Hospital Duran i Reynals), L'Hospitalet de Llobregat, 08908, Spain|Hospital Universitario Ramon y Cajal, Madrid, 28034, Spain|Hospital Regional Universitario de Malaga, Malaga, 29010, Spain|Hospital Universitario Virgen del Rocio, Sevilla, 41013, Spain|Hospital Universitari i Politecnic La Fe, Valencia, 46026, Spain|Kantonsspital Graubuenden, Chur, Graubuenden, 7000, Switzerland|Guy's and St Thomas' NHS Foundation Trust, London, SE1 9RT, United Kingdom|NIHR/Wellcome Trust Clinical Research Facility, Manchester, M13 9WL, United Kingdom|The Christie NHS Foundation Trust, Manchester, M20 4BX, United Kingdom Less <<
NCT06282991 Non-Small Cell Lung Carcinoma COMPLETED 2021-01-18 CHANG GUNG MEMORIAL HOSPITAL K... More >>aohsiung Branch, Kaohsiung City, 83301, Taiwan|Chung Shan Medical University Hospital, Taichung, 402, Taiwan|Taichung Veterans General Hospital, Taichung, 407219, Taiwan|National Taiwan University Hospital, Taipei, 100, Taiwan|Taipei Veterans General Hospital, Taipei, 11217, Taiwan|Chang Gung Memorial Hospital - Linkou Branch, Taoyuan City, 333, Taiwan Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.46mL

0.49mL

0.25mL

12.30mL

2.46mL

1.23mL

24.61mL

4.92mL

2.46mL

 

Historical Records

Categories